Advisory Services Network, LLC - CRISPR THERAPEUTICS AG ownership

CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 414 filers reported holding CRISPR THERAPEUTICS AG in Q4 2020. The put-call ratio across all filers is 1.10 and the average weighting 0.3%.

Quarter-by-quarter ownership
Advisory Services Network, LLC ownership history of CRISPR THERAPEUTICS AG
ValueSharesWeighting
Q3 2023$627,290
-23.1%
13,820
-4.9%
0.02%
-22.7%
Q2 2023$815,490
+25.6%
14,526
+1.2%
0.02%
+22.2%
Q1 2023$649,322
+552.2%
14,356
+486.2%
0.02%
+500.0%
Q4 2022$99,552
-50.7%
2,449
-20.6%
0.00%
-57.1%
Q3 2022$202,000
-47.1%
3,084
-50.9%
0.01%
-46.2%
Q2 2022$382,000
-54.6%
6,287
-53.2%
0.01%
-48.0%
Q1 2022$842,000
-10.0%
13,420
+8.7%
0.02%
-7.4%
Q4 2021$936,000
-34.6%
12,351
-3.4%
0.03%
-41.3%
Q3 2021$1,431,000
-29.0%
12,786
+2.7%
0.05%
-28.1%
Q2 2021$2,015,000
+62.8%
12,449
+22.6%
0.06%
+39.1%
Q1 2021$1,238,000
-2.7%
10,158
+22.2%
0.05%
-9.8%
Q4 2020$1,272,000
+1238.9%
8,310
+628.3%
0.05%
+1175.0%
Q3 2020$95,000
+227.6%
1,141
+69.3%
0.00%
+100.0%
Q1 2020$29,000
-29.3%
6740.0%0.00%0.0%
Q4 2019$41,000
+215.4%
674
+146.0%
0.00%
+100.0%
Q3 2019$13,0000.0%2740.0%0.00%0.0%
Q2 2019$13,000
+333.3%
274
+270.3%
0.00%
Q1 2019$3,000
+50.0%
740.0%0.00%
Q4 2018$2,000
-33.3%
740.0%0.00%
Q3 2018$3,000
-25.0%
740.0%0.00%
Q2 2018$4,000
-91.1%
74
-92.6%
0.00%
-100.0%
Q1 2018$45,000
+2150.0%
995
+895.0%
0.00%
Q3 2017$2,0000.0%1000.0%0.00%
Q2 2017$2,0000.0%1000.0%0.00%
Q1 2017$2,0001000.00%
Other shareholders
CRISPR THERAPEUTICS AG shareholders Q4 2020
NameSharesValueWeighting ↓
Versant Venture Management, LLC 498,558$27,989,04633.20%
Gilfoyle Management LLC 100$4,84215.90%
NEA Management Company, LLC 1,587,854$89,142,1246.80%
ARK Investment Management 7,338,447$411,980,3942.73%
Nikko Asset Management Americas, Inc. 3,533,357$198,327,3282.09%
Del-Sette Capital Management, LLC 33,661$1,889,7291.79%
Ikarian Capital, LLC 200,000$11,228,0001.79%
Ikarian Capital, LLC 200,000$11,228,0001.79%
Merlin Capital, Inc 8,802$494,1441.67%
Green Alpha Advisors, LLC 34,373$1,929,7001.27%
View complete list of CRISPR THERAPEUTICS AG shareholders